Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

NCT02097056 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT02097056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02097056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
Lead sponsor
Eisai Korea Inc.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
May 31, 2015
Enrollment
171 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease